Cargando…

Cognitive screening in treatment-naïve HIV-infected individuals in Hong Kong – a single center study

BACKGROUND: HIV-associated neurocognitive disorder (HAND) remains prevalent in the era of combination antiretroviral therapy (cART). The prevalence of HAND in Hong Kong is not known. METHODS: Between 2013 and 2015, 98 treatment-naïve HIV-1-infected individuals were referred to and screened by the AI...

Descripción completa

Detalles Bibliográficos
Autores principales: Chan, Fiona C.C., Chan, Phillip, Chan, Iris, Chan, Andrew, Tang, Tommy H. C., Lam, Wilson, Fong, W. C., Lee, M. P., Li, Patrick, Chan, Germaine H. F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6375138/
https://www.ncbi.nlm.nih.gov/pubmed/30760220
http://dx.doi.org/10.1186/s12879-019-3784-y
_version_ 1783395315675561984
author Chan, Fiona C.C.
Chan, Phillip
Chan, Iris
Chan, Andrew
Tang, Tommy H. C.
Lam, Wilson
Fong, W. C.
Lee, M. P.
Li, Patrick
Chan, Germaine H. F.
author_facet Chan, Fiona C.C.
Chan, Phillip
Chan, Iris
Chan, Andrew
Tang, Tommy H. C.
Lam, Wilson
Fong, W. C.
Lee, M. P.
Li, Patrick
Chan, Germaine H. F.
author_sort Chan, Fiona C.C.
collection PubMed
description BACKGROUND: HIV-associated neurocognitive disorder (HAND) remains prevalent in the era of combination antiretroviral therapy (cART). The prevalence of HAND in Hong Kong is not known. METHODS: Between 2013 and 2015, 98 treatment-naïve HIV-1-infected individuals were referred to and screened by the AIDS Clinical Service, Queen Elizabeth Hospital with (1) the International HIV Dementia Scale (IHDS), a screening tool that targets moderate to severe HAND, (2) the Montreal Cognitive Assessment (MoCA), a frequently used cognitive screening test and (3) the Patient Health Questionnare-9 (PHQ-9), a 9-item questionnaire that evaluates depression symptoms. Within the study period, 57 of them completed the second set of IHDS and MoCA at 6 months after baseline assessment. RESULTS: Most participants were male (94%), with a median age of 31 years. At baseline, 38 (39%) and 25 (26%) of them scored below the IHDS (≤10) and MoCA (25/26) cut-offs respectively. Poor IHDS performers also scored lower on MoCA (p = 0.039) but the correlation between IHDS and MoCA performance was weak (r = 0.29, p = 0.004). Up to a third of poor IHDS performers (13/38) showed moderate depression (PHQ-9 > 9). In the multivariable analysis, a lower education level (p = 0.088), a history of prior psychiatric illness (p = 0.091) and the presence of moderate depression (p = 0.079) tended to be significantly associated with poor IHDS performance. At follow-up, 54 out of 57 were on cART, of which 46 (85%) had achieved viral suppression. Their blood CD4+ T-lymphocytes and IHDS scores were higher at follow-up compared to baseline values (both p < 0.001) but their MoCA performance was similar at both assessments. Of note, 17 participants in this subgroup scored below the IHDS cut-off at both assessments. CONCLUSIONS: Poor IHDS performance, and likely cognitive impairment, was frequently observed in treatment-naïve HIV-infected individuals in our locality. A considerable proportion continued to score below the IHDS cut-off at 6 months after cART. Depression was frequently observed in this vulnerable population and was associated with poor IHDS performance. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12879-019-3784-y) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6375138
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-63751382019-02-26 Cognitive screening in treatment-naïve HIV-infected individuals in Hong Kong – a single center study Chan, Fiona C.C. Chan, Phillip Chan, Iris Chan, Andrew Tang, Tommy H. C. Lam, Wilson Fong, W. C. Lee, M. P. Li, Patrick Chan, Germaine H. F. BMC Infect Dis Research Article BACKGROUND: HIV-associated neurocognitive disorder (HAND) remains prevalent in the era of combination antiretroviral therapy (cART). The prevalence of HAND in Hong Kong is not known. METHODS: Between 2013 and 2015, 98 treatment-naïve HIV-1-infected individuals were referred to and screened by the AIDS Clinical Service, Queen Elizabeth Hospital with (1) the International HIV Dementia Scale (IHDS), a screening tool that targets moderate to severe HAND, (2) the Montreal Cognitive Assessment (MoCA), a frequently used cognitive screening test and (3) the Patient Health Questionnare-9 (PHQ-9), a 9-item questionnaire that evaluates depression symptoms. Within the study period, 57 of them completed the second set of IHDS and MoCA at 6 months after baseline assessment. RESULTS: Most participants were male (94%), with a median age of 31 years. At baseline, 38 (39%) and 25 (26%) of them scored below the IHDS (≤10) and MoCA (25/26) cut-offs respectively. Poor IHDS performers also scored lower on MoCA (p = 0.039) but the correlation between IHDS and MoCA performance was weak (r = 0.29, p = 0.004). Up to a third of poor IHDS performers (13/38) showed moderate depression (PHQ-9 > 9). In the multivariable analysis, a lower education level (p = 0.088), a history of prior psychiatric illness (p = 0.091) and the presence of moderate depression (p = 0.079) tended to be significantly associated with poor IHDS performance. At follow-up, 54 out of 57 were on cART, of which 46 (85%) had achieved viral suppression. Their blood CD4+ T-lymphocytes and IHDS scores were higher at follow-up compared to baseline values (both p < 0.001) but their MoCA performance was similar at both assessments. Of note, 17 participants in this subgroup scored below the IHDS cut-off at both assessments. CONCLUSIONS: Poor IHDS performance, and likely cognitive impairment, was frequently observed in treatment-naïve HIV-infected individuals in our locality. A considerable proportion continued to score below the IHDS cut-off at 6 months after cART. Depression was frequently observed in this vulnerable population and was associated with poor IHDS performance. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12879-019-3784-y) contains supplementary material, which is available to authorized users. BioMed Central 2019-02-13 /pmc/articles/PMC6375138/ /pubmed/30760220 http://dx.doi.org/10.1186/s12879-019-3784-y Text en © The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Chan, Fiona C.C.
Chan, Phillip
Chan, Iris
Chan, Andrew
Tang, Tommy H. C.
Lam, Wilson
Fong, W. C.
Lee, M. P.
Li, Patrick
Chan, Germaine H. F.
Cognitive screening in treatment-naïve HIV-infected individuals in Hong Kong – a single center study
title Cognitive screening in treatment-naïve HIV-infected individuals in Hong Kong – a single center study
title_full Cognitive screening in treatment-naïve HIV-infected individuals in Hong Kong – a single center study
title_fullStr Cognitive screening in treatment-naïve HIV-infected individuals in Hong Kong – a single center study
title_full_unstemmed Cognitive screening in treatment-naïve HIV-infected individuals in Hong Kong – a single center study
title_short Cognitive screening in treatment-naïve HIV-infected individuals in Hong Kong – a single center study
title_sort cognitive screening in treatment-naïve hiv-infected individuals in hong kong – a single center study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6375138/
https://www.ncbi.nlm.nih.gov/pubmed/30760220
http://dx.doi.org/10.1186/s12879-019-3784-y
work_keys_str_mv AT chanfionacc cognitivescreeningintreatmentnaivehivinfectedindividualsinhongkongasinglecenterstudy
AT chanphillip cognitivescreeningintreatmentnaivehivinfectedindividualsinhongkongasinglecenterstudy
AT chaniris cognitivescreeningintreatmentnaivehivinfectedindividualsinhongkongasinglecenterstudy
AT chanandrew cognitivescreeningintreatmentnaivehivinfectedindividualsinhongkongasinglecenterstudy
AT tangtommyhc cognitivescreeningintreatmentnaivehivinfectedindividualsinhongkongasinglecenterstudy
AT lamwilson cognitivescreeningintreatmentnaivehivinfectedindividualsinhongkongasinglecenterstudy
AT fongwc cognitivescreeningintreatmentnaivehivinfectedindividualsinhongkongasinglecenterstudy
AT leemp cognitivescreeningintreatmentnaivehivinfectedindividualsinhongkongasinglecenterstudy
AT lipatrick cognitivescreeningintreatmentnaivehivinfectedindividualsinhongkongasinglecenterstudy
AT changermainehf cognitivescreeningintreatmentnaivehivinfectedindividualsinhongkongasinglecenterstudy